We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+15.66%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$492M
AUM Growth
+$38.3M
Cap. Flow
-$11.5M
Cap. Flow %
-2.34%
Top 10 Hldgs %
75.23%
Holding
25
New
2
Increased
7
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$23.8M
2
PACB icon
Pacific Biosciences
PACB
+$12.5M
3
ARGX icon
argenx
ARGX
+$9.41M
4
NTRA icon
Natera
NTRA
+$4.75M
5
DXCM icon
DexCom
DXCM
+$3.39M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$25.3M
2
OM icon
Outset Medical
OM
+$16.3M
3
DHR icon
Danaher
DHR
+$8.45M
4
IQV icon
IQVIA
IQV
+$6.67M
5
TMDX icon
Transmedics
TMDX
+$5.99M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICLR icon
1
Icon
ICLR
$12.9B
$46.7M 9.5%
165,100
-21,100
-11% -$5.46M
ILMN icon
2
Illumina
ILMN
$29B
$44.4M 9.02%
327,679
+206,476
+170% +$23.8M
NTRA icon
3
Natera
NTRA
$46.4B
$43.3M 8.79%
690,862
+95,168
+16% +$4.75M
IQV icon
4
IQVIA
IQV
$40B
$40.2M 8.16%
173,595
-32,500
-16% -$6.67M
DXCM icon
5
DexCom
DXCM
$33.2B
$38.4M 7.8%
309,318
+33,213
+12% +$3.39M
UTHR icon
6
United Therapeutics
UTHR
$22.7B
$37.6M 7.63%
170,838
– –
DHR icon
7
Danaher
DHR
$146B
$36.5M 7.42%
157,785
-39,711
-20% -$8.45M
ARGX icon
8
argenx
ARGX
$54.2B
$32.2M 6.54%
84,590
+20,190
+31% +$9.41M
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$29B
$26.2M 5.32%
136,756
– –
TMDX icon
10
Transmedics
TMDX
$3.05B
$24.9M 5.05%
314,855
-99,350
-24% -$5.99M
INSP icon
11
Inspire Medical Systems
INSP
$1.73B
$23.1M 4.69%
113,503
+20,260
+22% +$3.28M
SRPT icon
12
Sarepta Therapeutics
SRPT
$1.79B
$18.3M 3.71%
189,356
+15,144
+9% +$1.45M
PACB icon
13
Pacific Biosciences
PACB
$357M
$14.9M 3.04%
+1,522,721
New +$12.5M
ISRG icon
14
Intuitive Surgical
ISRG
$138B
$14.6M 2.97%
43,390
– –
PRCT icon
15
Procept Biorobotics
PRCT
$1.26B
$14.1M 2.87%
337,218
– –
FDMT icon
16
4D Molecular Therapeutics
FDMT
$572M
$8.87M 1.8%
437,911
– –
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.94B
$7.37M 1.5%
330,830
+63,200
+24% +$1.42M
ADPT icon
18
Adaptive Biotechnologies
ADPT
$4.09B
$5.95M 1.21%
1,214,860
– –
FUSN
19
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$5.57M 1.13%
579,769
– –
GH icon
20
Guardant Health
GH
$22.8B
$3.25M 0.66%
120,109
-84,752
-41% -$2.22M
IMCR icon
21
Immunocore
IMCR
$1.73B
$3.16M 0.64%
+46,300
New +$2.41M
LNTH icon
22
Lantheus
LNTH
$6.59B
$2.68M 0.54%
43,200
-373,500
-90% -$25.3M
OM icon
23
Outset Medical
OM
$94M
– –
-99,634
Closed -$16.3M
PNT
24
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-306,142
Closed -$2.04M
CMAX
25
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
– –
-23,825
Closed -$1.52M

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q4 2023 Portfolio in Review

As of Q4 2023, Eagle Health Investments held 25 positions worth $492M, up 8.4% from $454M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Eagle Health Investments's Q4 2023 filing shows 2 new, 7 increased, 6 reduced and 3 closed positions. Its largest new stake was Pacific Biosciences: 1,522,721 shares worth $14.9M. The largest sale was Lantheus, an estimated $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Eagle Health Investments's largest Q4 2023 buy was Pacific Biosciences: 1,522,721 shares worth $14.9M.
  • Eagle Health Investments added most to Illumina in Q4 2023, an estimated $23.8M increase.
  • Eagle Health Investments's biggest Q4 2023 reduction was Lantheus, cutting an estimated $25.3M.
  • Eagle Health Investments fully exited Outset Medical in Q4 2023, selling an estimated $16.3M.
  • Eagle Health Investments's ten largest holdings make up 75% of its $492M portfolio in Q4 2023.
  • Eagle Health Investments opened 2 new positions and closed 3 in Q4 2023.
  • Eagle Health Investments's portfolio value rose 8.4% quarter-over-quarter to $492M.

Based on Eagle Health Investments's 13F filing for Q4 2023, filed 12 Feb 2024.